Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Long-Term Debt Issuances (2016 - 2021)

Historic Long-Term Debt Issuances for Creative Medical Technology Holdings (CELZ) over the last 12 years, with Q3 2021 value amounting to $3.7 million.

  • Creative Medical Technology Holdings' Long-Term Debt Issuances changed N/A to $3.7 million in Q3 2021 from the same period last year, while for Jun 2022 it was $3.7 million, marking a year-over-year increase of 151644.59%. This contributed to the annual value of $3.9 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q3 2021, Creative Medical Technology Holdings' Long-Term Debt Issuances is $3.7 million.
  • Creative Medical Technology Holdings' 5-year Long-Term Debt Issuances high stood at $3.7 million for Q3 2021, and its period low was -$145000.0 during Q2 2020.
  • Moreover, its 5-year median value for Long-Term Debt Issuances was $254925.0 (2018), whereas its average is $467420.1.
  • As far as peak fluctuations go, Creative Medical Technology Holdings' Long-Term Debt Issuances soared by 139118.47% in 2017, and later tumbled by 22719.3% in 2020.
  • Creative Medical Technology Holdings' Long-Term Debt Issuances (Quarter) stood at $107000.0 in 2017, then soared by 298.93% to $426855.0 in 2018, then crashed by 40.14% to $255500.0 in 2019, then tumbled by 156.75% to -$145000.0 in 2020, then soared by 2625.0% to $3.7 million in 2021.
  • Its last three reported values are $3.7 million in Q3 2021, $91860.0 for Q2 2021, and $134640.0 during Q1 2021.